https://doi.org/10.55788/4c3d3f95
Black Americans are disproportionately affected by hypertension and chronic kidney disease, with suboptimal healthy-diet access and knowledge being a potential contributing factor, according to Prof. Diedre C. Crews (Johns Hopkins University School of Medicine Equity, MD, USA). The Dietary Approaches to Stop Hypertension (DASH) diet is associated with better cardiovascular and kidney health, especially in Black Americans. In the 1-year, Five, Plus Nuts and Beans for Kidneys Trial (NCT03299816), 150 Black adults (≥21 years) with hypertension, UACR 30 to <1,000 mg/g, and eGFR ≥30 mL/min/1.73m2 were randomised (1:1) to either a Self-Shopping DASH (S-DASH) diet (US$30/week food allowance without nutritional advice for 4 months only) or to a Coaching DASH (C-DASH) diet (US$30/week food allowance with advice on buying high-potassium foods for 4 months, followed by advice without food allowance for 8 months).
The primary outcome was percent change in UACR at 4 months; secondary outcomes were change in systolic blood pressure at 4 months and UACR at 1 year. Participants had a mean age of 60 years, mean BMI 34 kg/m2, and 44% had self-reported diabetes. There was a higher percentage of male participants in the S-DASH group (44%) versus the C-DASH group (29%); other baseline characteristics were well balanced between groups. The mean systolic blood pressure was 129 mmHg and eGFR was 75 ml/min/1.73m2. The 4-month results showed a 28.6% decline in UACR in the C-DASH group (n=67) versus a −5.6% decline in the S-DASH group (n=72). The decrease in diastolic blood pressure was −2.1 mmHg in the C-DASH group versus −0.3% in the S-DASH group; the urine potassium decline was 7.0% versus 0.4%, respectively. In the subgroup of patients with severely increased UACR, the C-DASH group showed a 73% decrease in UACR and the S-DASH group a 21% increase (P=0.01). Statistically significant greater increases were observed in potassium and fruit and vegetable consumption in the C-DASH group versus the S-DASH group. There was also a suggestion of benefit for those with diabetes (P=0.09). “Regarding safety, only 1 C-DASH participant had potassium >5.5 mmol/L; no glucose values >400 were observed and no hospitalisations deemed related to the study protocol. Further dietary interventions that incorporate coaching/health education along with healthy foods provision may better address kidney health inequities,” said Prof. Crews [1].
- Crews DC, et al. Dietary Intervention Trial for Hypertensive Black Adults With CKD. FR-OR64, ASN Kidney Week 2022, 3–6 Nov.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« Cemdisiran shows promise in IgA nephropathy Next Article
Medication-targeted alerts for the risk of AKI »
« Cemdisiran shows promise in IgA nephropathy Next Article
Medication-targeted alerts for the risk of AKI »
Table of Contents: ASN 2022
Featured articles
Chronic Kidney Disease
VALOR-CKD trial did not show any benefits for veverimer
EMPA-KIDNEY: empagliflozin slashes kidney disease progression or CV death
Combining UACR and GFR improves prediction of drug effect in CKD phase 2 trials
Dapagliflozin reduces number of hospitalisations in patients with CKD
Novel MSC therapy appears safe and effective in preventing decline in eGFR
Dapagliflozin improves anaemia in patients with CKD with or without T2D
Kidney Transplantation and Dialysis
Balanced crystalloid solution better for deceased donor kidney transplantations
Modified donor blood cells seem a promising option in kidney transplant recipients
Cooler dialysate does not offer any clinical benefits
Antiviral effect of MAU868 against BK virus prompts further research
General Nephrology
Medication-targeted alerts for the risk of AKI
Coaching with a DASH diet improves albuminuria
Cemdisiran shows promise in IgA nephropathy
Long-term nephroprotective effects of sparsentan in FSGS
Encaleret normalises mineral homeostasis in patients with ADH1
Adding voclosporin to MMF and steroids results in long-term higher CRR in severe lupus nephritis
Selonsertib poses risk of AKI in patients with DKD
Significantly higher risk of overcorrection in hyponatraemic patients with standard bolus infusion
Lowering blood pressure intervention favourable for CV outcomes
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com